IL125951A - A pharmaceutical composition comprising a piperazinyl-heterocyclic compound for treating tourette's syndrome, obsessive compulsive disorder, chronic motor or vocal tic disorder in a mammal - Google Patents

A pharmaceutical composition comprising a piperazinyl-heterocyclic compound for treating tourette's syndrome, obsessive compulsive disorder, chronic motor or vocal tic disorder in a mammal

Info

Publication number
IL125951A
IL125951A IL12595198A IL12595198A IL125951A IL 125951 A IL125951 A IL 125951A IL 12595198 A IL12595198 A IL 12595198A IL 12595198 A IL12595198 A IL 12595198A IL 125951 A IL125951 A IL 125951A
Authority
IL
Israel
Prior art keywords
disorder
mammal
syndrome
piperazinyl
obsessive compulsive
Prior art date
Application number
IL12595198A
Other languages
English (en)
Other versions
IL125951A0 (en
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL125951A0 publication Critical patent/IL125951A0/xx
Publication of IL125951A publication Critical patent/IL125951A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Photoreceptors In Electrophotography (AREA)
IL12595198A 1997-09-05 1998-08-27 A pharmaceutical composition comprising a piperazinyl-heterocyclic compound for treating tourette's syndrome, obsessive compulsive disorder, chronic motor or vocal tic disorder in a mammal IL125951A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5798797P 1997-09-05 1997-09-05

Publications (2)

Publication Number Publication Date
IL125951A0 IL125951A0 (en) 1999-04-11
IL125951A true IL125951A (en) 2003-09-17

Family

ID=22013937

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12595198A IL125951A (en) 1997-09-05 1998-08-27 A pharmaceutical composition comprising a piperazinyl-heterocyclic compound for treating tourette's syndrome, obsessive compulsive disorder, chronic motor or vocal tic disorder in a mammal

Country Status (17)

Country Link
US (1) US6127373A (de)
EP (1) EP0901789B1 (de)
JP (1) JP3004969B2 (de)
KR (1) KR100621249B1 (de)
AT (1) ATE350037T1 (de)
AU (1) AU732157B2 (de)
CA (1) CA2246584C (de)
CY (1) CY1106402T1 (de)
DE (1) DE69836783T2 (de)
DK (1) DK0901789T3 (de)
ES (1) ES2278405T3 (de)
IL (1) IL125951A (de)
MY (1) MY122052A (de)
NZ (1) NZ331742A (de)
PT (1) PT901789E (de)
TW (1) TW448048B (de)
ZA (1) ZA988102B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL127497A (en) * 1997-12-18 2002-07-25 Pfizer Prod Inc Medicinal products containing piperazinyl-heterocyclic compounds for the treatment of psychiatric disorders
EA200500342A1 (ru) * 2002-09-17 2005-08-25 УОРНЕР-ЛАМБЕРТ КОМПАНИ Эл-Эл-Си Гетероциклические замещённые пиперазины для лечения шизофрении
CA2498215A1 (en) * 2002-10-28 2004-05-06 Warner-Lambert Company Llc Oxindole substituted piperazine derivatives
BRPI0410419A (pt) * 2003-05-16 2006-05-30 Pfizer Prod Inc tratamento para a ansiedade com ziprasidona
KR20060009938A (ko) * 2003-05-16 2006-02-01 화이자 프로덕츠 인코포레이티드 양극성 장애 및 연관된 증상의 치료
EP1626722A1 (de) * 2003-05-16 2006-02-22 Pfizer Products Inc. Ziprasidon zur verbesserung der wahrnehmung
CA2525366A1 (en) * 2003-05-16 2004-11-25 Pfizer Products Inc. Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines
JP2007502856A (ja) * 2003-05-16 2007-02-15 ファイザー・プロダクツ・インク 精神病性障害および抑うつ性障害の治療
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
MA41169A (fr) * 2014-12-17 2017-10-24 Acraf Composés antibactériens à large spectre d'activité
US12637461B2 (en) 2022-10-18 2026-05-26 Pfizer Inc. Compounds for the activation of AMPK

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US4883795A (en) * 1988-01-22 1989-11-28 Pfizer Inc. Piperazinyl-heterocyclic compounds
DE3923045A1 (de) * 1989-07-13 1991-01-17 Merck Patent Gmbh Indolderivate
US5314885A (en) * 1992-09-11 1994-05-24 Mcneilab, Inc. Cyclic benzylamino, benzylamido, and benzylimido antipsychotic agents

Also Published As

Publication number Publication date
DK0901789T3 (da) 2007-04-10
JP3004969B2 (ja) 2000-01-31
ES2278405T3 (es) 2007-08-01
CA2246584C (en) 2002-09-24
ZA988102B (en) 2000-03-22
AU732157B2 (en) 2001-04-12
ATE350037T1 (de) 2007-01-15
CA2246584A1 (en) 1999-03-05
CY1106402T1 (el) 2011-04-06
DE69836783T2 (de) 2007-10-31
MY122052A (en) 2006-03-31
US6127373A (en) 2000-10-03
EP0901789B1 (de) 2007-01-03
DE69836783D1 (de) 2007-02-15
IL125951A0 (en) 1999-04-11
AU8310698A (en) 1999-03-18
PT901789E (pt) 2007-03-30
JPH11180874A (ja) 1999-07-06
TW448048B (en) 2001-08-01
KR19990029571A (ko) 1999-04-26
NZ331742A (en) 2000-07-28
EP0901789A1 (de) 1999-03-17
KR100621249B1 (ko) 2006-10-24

Similar Documents

Publication Publication Date Title
AU697679B2 (en) Treatment of tinnitis using neuroprotective agents
HU9600834D0 (en) Quinazoline derivatives
DE69508463D1 (de) Propiophenonderivate und Verfahren zu deren Herstellung
BG106586A (en) Pyrazolopyramidines as therapeutic agents
ITRM990338A0 (it) Composizione dietetica o farmaceutica utile per la prevenzione o il trattamento dell'iperossaluria.
EP1600168A3 (de) Pyrrolidinacetamid-Derivat, allein oder kombiniert, zur Behandlung von ZNS-Störungen
IL136044A (en) 2-aminoacetamide derivatives and pharmaceutical compositions containing the same
IT1307047B1 (it) Apparecchiatura per il trattamento umidificato dell'apnea da sonno.
BG105810A (en) Camptothecin derivatives having antitumor activity
AP9701041A0 (en) Pyridylpyrrole compounds.
SI2017276T1 (sl) Fenil-karboksamidne spojine, uporabne za tretiranje bolečine
CY1106402T1 (el) Μεθοδος θepαπειας του συνδρομου tourette
ES2180564T3 (es) 2-fenil-3-azoilbenzotiofenos para aumentar la expresion de trombomodulina.
NZ516290A (en) Substituted phenoxyacetic acids
WO1999033450A3 (en) Pharmaceutical composition containing sibutramine and orlistat
GB9310095D0 (en) Therapeutic compounds
WO1996040743A3 (en) Inhibitors of factor xa
AU6234099A (en) Gene therapy of alzheimer's disease by delivery of an encoded apoliprotein
EP0760239A3 (de) Pyrrol-, Imidazol-, und indolderivate zur Verwendung in der Krebstherapie
CA2260863A1 (en) Treatment of psychotic disorders
HU0102987D0 (en) Pharmaceutical composition for treating parkinson's disease comprising astrocyte function-improving agent as active ingredient
CA2387394A1 (en) Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder
SE9803623D0 (sv) New therapeutic application
EP1714676A3 (de) N-substituierte 1,5-dideoxy-1,5-imino-D-glucitol Verbindungen für die Therapie von Hepatitis Virus Infektionen
RU95122486A (ru) Средство для лечения тикозных гиперкинезов

Legal Events

Date Code Title Description
FF Patent granted
KB20 Patent renewed for 20 years
EXP Patent expired